US FDA's drug centre puts advertising topics on 2010 guidance agenda
This article was originally published in Scrip
Executive Summary
The US Food and Drug Administration's Center for Drug Evaluation and Research (CDER) has published a list of guidance documents that it is considering for development in 2010.